Venus Remedies Limited (VENUSREM) โ Board Meeting | 20 August 2026 (2 announcements)
Venus Remedies held its 37th Annual General Meeting on 20th August 2026 via video conference, where shareholders approved the audited standalone and consolidated financial statements for FY2025-26, declared a final dividend of Rs.10 per share, reappointed directors including Ashutosh Jain and Peeyush Jain, appointed Saransh Chaudhary as Executive Director, and ratified auditor remuneration of Rs.1.1 lakh. The meeting included electronic voting with results to be announced within 48 hours.
Venus Remedies Limited announced board appointments and reappointments at its 37th Annual General Meeting on August 20, 2026, including Saransh Chaudhary as Executive Director for five years, Dr. Gurminder Singh Bedi as Non-Executive Independent Director, and reappointments of Manu Chaudhary as Joint Managing Director and Savita Gupta as Independent Director for five-year terms starting October and December 2026 respectively.
About Venus Remedies Limited (VENUSREM)
Healthcare ยท Pharmaceuticals ยท Listed on NSE
๐ก Get AI alerts when VENUSREM files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track VENUSREM โ Free๐ก Ask AI about this filing
๐ More VENUSREM filings
- Announcement โ 25 September 2026Venus Remedies announced that its insider trading window will close on September 25, 2026, following...
- share transfer โ 8 September 2026Venus Remedies announced a special window for re-lodging transfer requests of physical shares via so...
- ๐ด Annual Report โ 24 July 2026Venus Remedies Limited announced its 37th AGM on August 20, 2026, via video conferencing, with resol...
- Announcement โ 18 July 2026Venus Remedies Limited issued a social media announcement urging shareholders to update their KYC de...
- Financial Results โ 25 June 2026Venus Remedies Limited announced that its designated insiders must remain in a trading window closur...
๐ฅ Also filed on 20 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when VENUSREM files new disclosures
Track VENUSREM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VENUSREM โ FreeFree account ยท 2 AI queries/day